According to the latest equity disclosure information of the Stock Exchange, from January 17 to January 18, 2022, Jacobson Research Pharmaceutical (02633.HK) was increased by the executive director, chairman and chief executive officer Cen Guangye at an average price of HK$0.688-0.69 per share in the market, involving a total of about HK$138,000.
After the increase in shareholding, the latest number of shares held by Cen Guangye was 1,152,860,000 shares, and the shareholding ratio increased from 59.59% to 59.60%.
This article originated from Grand Gateway
![Striking Similarity (III)[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)